3Caldwell PHY, Murphy SB, Butow PN, et al. Clinical trials in children [J]. Lancet, 2004, 364: 803-811. 被引量：1
4Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in paediatric in/out-patients : a systematic review an meta-analysis of prospective studies [ J]. Br J Clin Pharmacol, 2001, 52: 77-83. 被引量：1
5Buck ML. The FDA Modernization Act of 1997: impact on pediatric medicine [ J]. Pediatric Pharmacotherapy, 2000, 6: 12. 被引量：1
6Cohen SN. The pediatric pharmacology research unit (PPRU) network and its role in meeting pediatric labeling needs [ J ]. Ediatrics, 1999, 104: 644-645. 被引量：1
7Wang L, Zao DY, Zhang ZH. Trial of antiepilepsirine (AES) in children with epilepsy [ J ]. Brain and Development, 1999, 21: 36-40. 被引量：1
8Menson EN, Walker AS, Gibb DM. Clinical trials in children [J]. Lancet, 2004, 364(18/25): 2176-2177. 被引量：1
9Antonio C, Chiara P, Maurizio B. Public Disclosure of Clinical Trials in Children [J]. Current therapetic research, 2002, 63(10) : 707-716. 被引量：1
10Ellis P. Improving recruitment to cancer clinical trials [ J ]. Cancer Forum, 1999, 23: 153-55. 被引量：1
